• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者腹主动脉瘤的基质生物学:负相关的潜在机制

Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association.

作者信息

Norman Paul E, Davis Timothy M E, Le Max Tan Quoc, Golledge Jonathan

机构信息

School of Surgery and Pathology, University of Western Australia, Fremantle, Western Australia.

出版信息

Connect Tissue Res. 2007;48(3):125-31. doi: 10.1080/03008200701331524.

DOI:10.1080/03008200701331524
PMID:17522995
Abstract

Several case-control studies have shown a significant negative association between diabetes and abdominal aortic aneurysm (AAA). This interaction has the potential to further our understanding of these two diseases but has attracted little research. The changes seen in the walls of aneurysmal aortas include inflammation and the activation of proteolytic pathways resulting in loss of elastin and other structural proteins. In contrast, diabetes is associated with increased synthesis and reduced degradation of matrix. The deposition of advanced glycation end products also renders vascular matrix resistant to proteolysis in diabetic patients. The aim of our present minireview is to compare the changes in matrix biology seen in diabetes and AAA and to explore molecular mechanisms that may explain the negative association and identify possible therapeutic implications.

摘要

多项病例对照研究表明,糖尿病与腹主动脉瘤(AAA)之间存在显著的负相关。这种相互作用有可能加深我们对这两种疾病的理解,但目前相关研究较少。动脉瘤主动脉壁的变化包括炎症反应以及蛋白水解途径的激活,导致弹性蛋白和其他结构蛋白的丢失。相比之下,糖尿病与基质合成增加和降解减少有关。晚期糖基化终末产物的沉积也使糖尿病患者的血管基质对蛋白水解具有抗性。我们本次小型综述的目的是比较糖尿病和腹主动脉瘤中基质生物学的变化,探讨可能解释这种负相关的分子机制,并确定可能的治疗意义。

相似文献

1
Matrix biology of abdominal aortic aneurysms in diabetes: mechanisms underlying the negative association.糖尿病患者腹主动脉瘤的基质生物学:负相关的潜在机制
Connect Tissue Res. 2007;48(3):125-31. doi: 10.1080/03008200701331524.
2
Aortic length changes during abdominal aortic aneurysm formation, expansion and stabilisation in a rat model.在大鼠模型中,腹主动脉瘤形成、扩张和稳定过程中的主动脉长度变化。
Eur J Vasc Endovasc Surg. 2010 Oct;40(4):468-74. doi: 10.1016/j.ejvs.2010.05.001. Epub 2010 Jun 15.
3
Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions.糖尿病患者腹主动脉瘤扩张率降低可能与异常的单核细胞-基质相互作用有关。
Eur Heart J. 2008 Mar;29(5):665-72. doi: 10.1093/eurheartj/ehm557. Epub 2008 Feb 9.
4
Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs.腹主动脉瘤作为一种复杂的多因素疾病:炎症基因多态性、自身免疫特征及基质金属蛋白酶的现状之间的相互作用
Ann N Y Acad Sci. 2006 Nov;1085:117-32. doi: 10.1196/annals.1383.025.
5
Elastin stabilization for treatment of abdominal aortic aneurysms.用于治疗腹主动脉瘤的弹性蛋白稳定化
Circulation. 2007 Apr 3;115(13):1729-37. doi: 10.1161/CIRCULATIONAHA.106.672873. Epub 2007 Mar 19.
6
Overexpression of PAI-1 prevents the development of abdominal aortic aneurysm in mice.纤溶酶原激活物抑制剂-1(PAI-1)的过表达可预防小鼠腹主动脉瘤的发展。
Gene Ther. 2008 Feb;15(3):224-32. doi: 10.1038/sj.gt.3303069. Epub 2007 Nov 22.
7
Vascular aneurysms: a side-splitting affair.血管动脉瘤:一件引人发笑的事。
Cardiovasc Res. 1996 Feb;31(2):224-30.
8
The morphology of elastin in non-specific and inflammatory abdominal aortic aneurysms. A comparative transmission, scanning and immunoelectronmicroscopy study.非特异性和炎性腹主动脉瘤中弹性蛋白的形态学。一项透射、扫描和免疫电子显微镜对比研究。
J Submicrosc Cytol Pathol. 1995 Jan;27(1):75-81.
9
Chronic inflammation, immune response, and infection in abdominal aortic aneurysms.腹主动脉瘤中的慢性炎症、免疫反应和感染
Eur J Vasc Endovasc Surg. 2006 May;31(5):453-63. doi: 10.1016/j.ejvs.2005.10.030. Epub 2006 Jan 18.
10
Activators of plasminogen and the progression of small abdominal aortic aneurysms.纤溶酶原激活剂与小腹部主动脉瘤的进展
Ann N Y Acad Sci. 2006 Nov;1085:139-50. doi: 10.1196/annals.1383.023.

引用本文的文献

1
Atherosclerosis in patients with cervical artery dissection.颈动脉夹层患者的动脉粥样硬化
Eur Stroke J. 2025 Mar;10(1):198-205. doi: 10.1177/23969873241274547. Epub 2024 Sep 4.
2
Endovascular Treatment of Abdominal Aortic Aneurysm: Impact of Diabetes on Endoleaks and Reintervention.腹主动脉瘤的血管内治疗:糖尿病对内漏和再次干预的影响。
J Clin Med. 2024 Jun 17;13(12):3551. doi: 10.3390/jcm13123551.
3
Pathogenesis and management of abdominal aortic aneurysm.腹主动脉瘤的发病机制与处理。
Eur Heart J. 2023 Aug 1;44(29):2682-2697. doi: 10.1093/eurheartj/ehad386.
4
Clinical features and prognosis of patients with and without diabetes mellitus undergoing endovascular aortic aneurysm repair.接受血管内主动脉瘤修复术的糖尿病患者与非糖尿病患者的临床特征和预后。
BMC Endocr Disord. 2022 Apr 7;22(1):92. doi: 10.1186/s12902-022-01008-4.
5
Exploring the Correlation and Protective Role of Diabetes Mellitus in Aortic Aneurysm Disease.探索糖尿病在主动脉瘤疾病中的相关性及保护作用。
Front Cardiovasc Med. 2021 Nov 8;8:769343. doi: 10.3389/fcvm.2021.769343. eCollection 2021.
6
Systematic review and Meta-Analysis of Mendelian randomisation analyses of Abdominal aortic aneurysms.腹主动脉瘤孟德尔随机化分析的系统评价与Meta分析
Int J Cardiol Heart Vasc. 2021 Jul 8;35:100836. doi: 10.1016/j.ijcha.2021.100836. eCollection 2021 Aug.
7
Aberrant Mitochondrial Dynamics: An Emerging Pathogenic Driver of Abdominal Aortic Aneurysm.异常的线粒体动力学:腹主动脉瘤的一个新兴致病驱动因素。
Cardiovasc Ther. 2021 Jun 16;2021:6615400. doi: 10.1155/2021/6615400. eCollection 2021.
8
Abdominal Aortic Aneurysm: Evolving Controversies and Uncertainties.腹主动脉瘤:不断演变的争议与不确定性
Int J Angiol. 2018 Jun;27(2):58-80. doi: 10.1055/s-0038-1657771. Epub 2018 May 29.
9
Chronic Kidney Disease Is Positively and Diabetes Mellitus Is Negatively Associated with Abdominal Aortic Aneurysm.慢性肾脏病与腹主动脉瘤呈正相关,而糖尿病与腹主动脉瘤呈负相关。
PLoS One. 2016 Oct 20;11(10):e0164015. doi: 10.1371/journal.pone.0164015. eCollection 2016.
10
Epigenetics and Peripheral Artery Disease.表观遗传学与外周动脉疾病
Curr Atheroscler Rep. 2016 Apr;18(4):15. doi: 10.1007/s11883-016-0567-4.